{"SPADE_UN_16342": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16342", "Peptide Name": "TRPs P1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "RKRWWRWWKWWKR", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/P33432"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HeLa  (IC50=32 μg/mL)", "Hemolytic Activity": "Sheep erythrocytes:No hemolysis up tp 500 µg/ml", "Cytotoxicity": "NIH 3T3:IC50=250 µg/ml", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C108H146N34O14", "Mass": 2144.53, "PI": 12.0, "Net Charge": 7, "Hydrophobicity": -2.7, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Comments": "Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.", "Literature": [{"Title": "Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells", "Pubmed ID": "33207639", "Reference": "Int J Mol Sci. 2020 Nov 16;21(22)8624.", "Author": "Shagaghi N, Clayton AHA, Aguilar MI, Lee TH, Palombo EA, Bhave M.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33207639"}], "Frequent Amino Acids": "WRK", "Absent Amino Acids": "ACDEFGHILMNOPQSTUVY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07017", "Similarity": 1.0, "Sequence": "SRRARRSPRESGKKRKRKR"}, {"SPADE_ID": "SPADE_UN_02511", "Similarity": 1.0, "Sequence": "WKRVGRKRL"}, {"SPADE_ID": "SPADE_UN_05208", "Similarity": 1.0, "Sequence": "KRGWRKRWW"}]}}}